A voluntary agreement between the Government and the pharmaceutical industry.
The relationship between the pharmaceutical industry and healthcare professionals (HCPs) and healthcare organisations (HCOs) plays a vital role in the development and delivery of life-enhancing and life-saving medicines.
The Association of the British Pharmaceutical Industry (ABPI) and the BioIndustry Association (BIA) have welcomed the publication of "Continuity in the availability of goods for the EU and the UK", published today by the UK Government's Department for Exiting the European Union.
As a membership organisation we work with our member companies, and the expertise of the specialists they employ, to develop and present our points of view to UK and European governments, the public and to other stakeholders.
We are pleased to announce that Stephen Whitehead, ABPI Chief Executive, will be taking part in a live webinar, held in partnership with the PM Society, on 24 October at 9.30am.
Stephen will be reaching out to industry colleagues, discussing the future of the pharmaceutical industry, stakeholder realignment, and the role of marketing and the ABPI,
You can join the webinar and ask questions directly to Stephen by registering on the BrightTALK website.